Wall Street Analysts See a 357.36% Upside in Regenxbio (RGNX): Can the Stock Really Move This High?

Regenxbio (RGNX) closed the last trading session at $7.95, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $36.36 indicates a 357.4% upside potential.The average comprises 11 short-term price targets ranging from a low of $22 to a high of $52, with a standard deviation of $9.66. While the lowest estimate indicates an increase of 176.7% from the current price level, the m ...